The DOI matches its Crossref record; 206 of the 207 references it cites were found in a registry or an index.
The Pathophysiology of Fragile X (and What It Teaches Us about Synapses)
Open accessAbstract
Fragile X is the most common known inherited cause of intellectual disability and autism, and it typically results from transcriptional silencing of FMR1 and loss of the encoded protein, FMRP (fragile X mental retardation protein). FMRP is an mRNA-binding protein that functions at many synapses to inhibit local translation stimulated by metabotropic glutamate receptors (mGluRs) 1 and 5. Recent studies on the biology of FMRP and the signaling pathways downstream of mGluR1/5 have yielded deeper insight into how synaptic protein synthesis and plasticity are regulated by experience. This new knowledge has also suggested ways that altered signaling and synaptic function can be corrected in fragile X, and human clinical trials based on this information are under way.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FMRP has recently been reported to modulate the rate of translational elongation of mRNAs that encode synaptic proteins33, suggesting that the decrease in FMRP expression that occurs in Fragile X syndrome may result in the dysregulation of synaptic protein expression owing to an impairment in translational control23.”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [23]
In the citing paper
“Fragile X syndrome results from a trinucleotide expansion (CGG) in FMR1, which encodes fragile X mental retardation protein (FMRP).”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [23]
In the citing paper
“The CGG expansion occurs within the 5′ untranslated region of the FMRP mRNA, resulting in decreased translation of the FMRP mRNA and a decrease in the amount of FMRP expressed in neurons.”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [23]
In the citing paper
“In addition to these rare mutations, several widely studied syndromic disorders, such as Fragile X, with penetrant autism spectrum features have provided useful insight into the pathophysiology of ASD.”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [23]
In the citing paper
“For example, Fragile X syndrome — characterized by macroorchidism, connective-tissue disease, motor abnormalities, language deficits and impaired social interactions — is the leading cause of inherited intellectual disability and ASD23.”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [23]
In the citing paper
“This protein negatively regulates the translation of specific mRNAs at the synapse23,54.”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [23]
In the citing paper
“Several genes that are mutated in ASD — FMR1, TSC1, TSC2 and PTEN — have key roles in protein synthesis-dependent plasticity of synapses (Fig. 2)13,23.”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [23]
In the citing paper
“These findings are the basis of human clinical trials that aim to test the efficacy of mGluR5 antagonists for the treating Fragile X syndrome23,56–58.”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [23]
In the citing paper
“This suggests that these ASD candidate genes and FMRP may function in overlapping pathways.”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [23]
In the citing paper
“Many other FMRP targets have been shown to be involved in synaptic plasticity, and there is significant overlap between FMRP targets and ASD candidate genes, including NLGN3, NRXN1, SHANK3, PTEN, TSC1 and NF123,33.”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [23]
In the citing paper
“As the Ras–MAPK signalling pathway is crucial for activity-regulated protein synthesis, activity-dependent gene transcription and mGluR dependent synaptic plasticity23,25,95”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The molecular biology of memory storage: a dialogue between genes and synapses
Kandel, E. R. (2001) · Science · doi:10.1126/science.1067020 · Cited by 3,917
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., Verkert, A. J. M. H., Holden, J. J. A., Fenwick, R. G., Warren, S. T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90283-5 · Cited by 2,080
FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.013 · Cited by 2,072
Ferguson, S. S. G. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01478-9 · Cited by 1,827
The mGluR theory of fragile X mental retardation
Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580
Self-citationAbsence of expression of the FMR-1 gene in fragile X syndrome
Pieretti, M., Zhang, F., Fu, Y.-H., Warren, S. T., Oostra, B. A., Caskey, C. T., & Nelson, D. L. (1991) · Cell · doi:10.1016/0092-8674(91)90125-i · Cited by 1,476
Altered synaptic plasticity in a mouse model of fragile X mental retardation
Huber, K. M., Gallagher, S. M., Warren, S. T., & Bear, M. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122205699 · Cited by 1,349
Self-citationBrown, V., Jin, P., Ceman, S., Darnell, J. C., O'Donnell, W. T., Tenenbaum, S. A., Jin, X., Feng, Y., Wilkinson, K. D., Keene, J. D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00568-2 · Cited by 1,109
Fmr1 knockout mice: A model to study fragile X mental retardation
THEDUTCHBELGIANFRAGILEXCONSOR (1994) · Cell · doi:10.1016/0092-8674(94)90569-x · Cited by 1,108
Research works printed but not linked: 5
- Caudy AA, 2004, Methods Mol. Biol., 265, 59
- Dutch-Belgian Fragile X Consort, 1994, Cell, 78, 23
- Loesch DZ, 1995, Am. J. Hum. Genet., 57, 1408
- Meredith RM, 2010, Front. Synaptic Neurosci., 2, 10
- Westmark CJ, 2009, Int. J. Clin. Exp. Pathol., 3, 56
Cited by
Sorted by citations
Items 101–200 of 366
Radwan, B., Dvorak, D., & Fenton, A. A. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.01.003 · Cited by 63
Treatment of Neurodevelopmental Disorders in Adulthood
Ċastrén, E., Elgersma, Y., Maffei, L., & Hagerman, R. J. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.3287-12.2012 · Cited by 69
Impaired Presynaptic Long-Term Potentiation in the Anterior Cingulate Cortex ofFmr1Knock-out Mice
Koga, K., Liu, M., Qiu, S., Song, Q., O'Den, G., Chen, T., & Zhuo, M. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2644-14.2015 · Cited by 66
Fragile X mental retardation protein: A paradigm for translational control by RNA-binding proteins
Chen, E., & Joseph, S. (2015) · Biochimie · doi:10.1016/j.biochi.2015.02.005 · Cited by 66
Sunamura, N., Iwashita, S., Enomoto, K., Kadoshima, T., & Isono, F. (2018) · Scientific Reports · doi:10.1038/s41598-018-30025-4 · Cited by 62
Neuronal BC RNAs cooperate with eIF4B to mediate activity-dependent translational control
Eom, T., Muslimov, I. A., Tsokas, P., Berardi, V., Zhong, J. W., Sacktor, T. C., & Tiedge, H. (2014) · The Journal of Cell Biology · doi:10.1083/jcb.201401005 · Cited by 61
Scheyer, A. F., Wolf, M. E., & Tseng, K. Y. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4940-13.2014 · Cited by 62
FMR1 and Autism, an Intriguing Connection Revisited
Fyke, W., & Velinov, M. T. (2021) · Genes · doi:10.3390/genes12081218 · Cited by 60
Iliff, A. J., Renoux, A. J., Krans, A., Usdin, K., Sutton, M. A., & Todd, P. K. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds525 · Cited by 57
Kalinowska, M., Chávez, A. E., Lutzu, S., Castillo, P. E., Bukauskas, F. F., & Francesconi, A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.640136 · Cited by 61
Costa, L., Sardone, L. M., Lacivita, E., Leopoldo, M., & Ciranna, L. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00065 · Cited by 57
Gogliotti, R. G., Senter, R. K., Rook, J. M., Ghoshal, A., Zamorano, R., Malosh, C., Stauffer, S. R., Bridges, T. M., Bartolomé, J. M., Daniels, J. S., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw074 · Cited by 61
Targeted Reactivation of FMR1 Transcription in Fragile X Syndrome Embryonic Stem Cells
Haenfler, J. M., Skariah, G., Rodriguez, C. M., da Rocha, A. M., Parent, J. M., Smith, G. D., & Todd, P. K. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00282 · Cited by 59
McCamphill, P. K., Stoppel, L. J., Senter, R. K., Lewis, M. C., Heynen, A. J., Stoppel, D. C., Sridhar, V., Collins, K. A., Shi, X., Pan, J. Q., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aam8572 · Cited by 60
Self-citationStructure–Activity Relationships and Therapeutic Potentials of 5-HT7Receptor Ligands: An Update
Modica, M. N., Lacivita, E., Intagliata, S., Salerno, L., Romeo, G., Pittalà, V., & Leopoldo, M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01898 · Cited by 56
Ji, B., Higa, K. K., Kelsoe, J. R., & Zhou, X. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.06.012 · Cited by 55
Axonal ribosomes and mRNAs associate with fragile X granules in adult rodent and human brains
Akins, M. R., Berk-Rauch, H., Kwan, K. Y., Mitchell, M. E., Shepard, K. A., Korsak, L. I. T., Stackpole, E. E., Warner‐Schmidt, J. L., Šestan, N., Cameron, H. A., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw381 · Cited by 56
The Role of Rac GTPase in Dendritic Spine Morphogenesis and Memory
Costa, J. F., Dines, M., & Lamprecht, R. (2020) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2020.00012 · Cited by 58
Simmons, D. H., Titley, H. K., Hansel, C., & Mason, P. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.05.010 · Cited by 57
Lim, C., Hoang, E. T., Viar, K. E., Stornetta, R. L., Scott, M. M., & Zhu, J. (2014) · Genes & Development · doi:10.1101/gad.232470.113 · Cited by 54
Hyperexcitability and homeostasis in fragile X Syndrome.
Liu, X., Kumar, V., Tsai, N.-P., & Auerbach, B. D. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.805929 · Cited by 53
Clifton, N. E., Morisot, N., Girardon, S., Millan, M. J., & Loiseau, F. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2845-3 · Cited by 57
Ahmad, M., Shen, W., Li, W., Xue, Y., Zou, S., Xu, D., & Wang, W. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1293 · Cited by 53
Henry, F. E., Hockeimer, W., Chen, A., Mysore, S. P., & Sutton, M. A. (2017) · Molecular Brain · doi:10.1186/s13041-017-0330-y · Cited by 56
Regulation of RNA granules by FMRP and implications for neurological diseases
Lai, A., Valdez‐Sinon, A. N., & Bassell, G. J. (2020) · Traffic · doi:10.1111/tra.12733 · Cited by 57
Oxytocin as a Modulator of Synaptic Plasticity: Implications for Neurodevelopmental Disorders
Rajamani, K. T., Wagner, S., Grinevich, V., & Harony-Nicolas, H. (2018) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2018.00017 · Cited by 53
Chen, T., Lu, J.-S., Song, Q., Liu, M.-G., Koga, K., Descalzi, G., Li, Y.-Q., & Zhuo, M. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.44 · Cited by 52
Neuronal profilins in health and disease: Relevance for spine plasticity and Fragile X syndrome
Michaelsen‐Preusse, K., Zessin, S., Grigoryan, G., Scharkowski, F., Feuge, J., Remus, A., & Körte, M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516697113 · Cited by 56
Estimating individual contribution from group-based structural correlation networks
Saggar, M., Hosseini, S. M. H., Bruno, J. L., Quintin, E., Raman, M. M., Kesler, S. R., & Reiss, A. L. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.07.006 · Cited by 51
Mingrone, A., Kaffman, A., & Kaffman, A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.618593 · Cited by 50
Excess ribosomal protein production unbalances translation in a model of Fragile X Syndrome
Seo, S. S., Louros, S. R., Anstey, N. J., Gonzalez‐Lozano, M. A., Harper, C. B., Verity, N., Dando, O., Thomson, S. R., Darnell, J. C., Kind, P. C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30979-0 · Cited by 54
Notaras, M. J., Allen, M., Longo, F., Volk, N. L., Tóth, M., Jeon, N. L., Klann, E., & Colak, D. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0547-5 · Cited by 51
Fragile X syndrome: From targets to treatments
Wijetunge, L. S., Chattarji, S., Wyllie, D. J. A., & Kind, P. C. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.028 · Cited by 54
Zalfa, F., Panasiti, V., Carotti, S., Zingariello, M., Perrone, G., Sancillo, L., Pacini, L., Luciani, F., Roberti, V., D’Amico, S., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.521 · Cited by 48
Interneuron Dysfunction and Inhibitory Deficits in Autism and Fragile X Syndrome
Nomura, T. (2021) · Cells · doi:10.3390/cells10102610 · Cited by 51
Utami, K. H., Skotte, N. H., Colaço, A. R., Yusof, N. A. B. M., Sim, B., Yeo, X. Y., Bae, H.-G., Garcia-Miralles, M., Radulescu, C. I., Chen, Q., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.05.005 · Cited by 47
Drep-2 is a novel synaptic protein important for learning and memory
Andlauer, T. F. M., Scholz-Kornehl, S., Tian, R., Kirchner, M., Babikir, H. A., Depner, H., Loll, B., Quentin, C., Gupta, V., Holt, M. G., et al. (2014) · eLife · doi:10.7554/elife.03895 · Cited by 48
The role of neurotrophic factors in novel, rapid psychiatric treatments
Kim, J., He, M. J., Widmann, A. K., & Lee, F. S. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01717-x · Cited by 49
Transient Potassium Channels: Therapeutic Targets for Brain Disorders
Noh, W., Pak, S., Choi, G., Yang, S., & Yang, S. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00265 · Cited by 47
Valproate-Induced Neurodevelopmental Deficits inXenopus laevisTadpoles
James, E. J., Gu, J., Ramirez-Vizcarrondo, C. M., Hasan, M., Truszkowski, T. L. S., Tan, Y., Oupravanh, P. M., Khakhalin, A. S., & Aizenman, C. D. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4050-14.2015 · Cited by 47
Achuta, V. S., Grym, H., Putkonen, N., Louhivuori, V., Kärkkäinen, V., Koıstınaho, J., Roybon, L., & Castrén, M. L. (2016) · Developmental Neurobiology · doi:10.1002/dneu.22419 · Cited by 46
Treating a novel plasticity defect rescues episodic memory in Fragile X model mice
Wang, W., Cox, B. M., Jia, Y., Le, A. A., Cox, C. D., Jung, K., Hou, B., Piomelli, D., Gall, C. M., & LYNCH, G. S. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.221 · Cited by 45
Werner, C. T., Stefanik, M. T., Milovanovic, M., Caccamise, A. J., & Wolf, M. E. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2412-17.2018 · Cited by 46
Fragile X mental retardation protein regulates trans-synaptic signaling inDrosophila
Friedman, S. H., Dani, N., Rushton, E., & Broadie, K. S. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.012229 · Cited by 44
Fragile X mental retardation protein stimulates ribonucleoprotein assembly of influenza A virus
Zhou, Z. L., Cao, M., Guo, Y., Zhao, L., Wang, J., Jia, X., Li, J., Wang, C., Gabriel, G., Xue, Q., et al. (2014) · Nature Communications · doi:10.1038/ncomms4259 · Cited by 44
McDuffie, A. S., Banasik, A., Bullard, L., Potter, S. N., Feigles, R. T., Hagerman, R. J., & Abbeduto, L. (2017) · Developmental Neurorehabilitation · doi:10.1080/17518423.2017.1369189 · Cited by 43
Tao, J., Wu, H., Coronado, A. A., de Laittre, E. A., Osterweil, E. K., Zhang, Y., & Bear, M. F. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0672-16.2016 · Cited by 46
Self-citationCereblon Maintains Synaptic and Cognitive Function by Regulating BK Channel
Choi, T.-Y., Lee, S., Kim, Y.-J., Bae, J. R., Lee, K. M., Jo, Y., Kim, S., Lee, A.-R., Choi, S., Choi, L., et al. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2081-17.2018 · Cited by 42
A Spoken-Language Intervention for School-Aged Boys With Fragile X Syndrome
McDuffie, A., Machalicek, W., Bullard, L., Nelson, S., Mello, M., Tempero-Feigles, R., Castignetti, N., & Abbeduto, L. (2016) · American Journal on Intellectual and Developmental Disabilities · doi:10.1352/1944-7558-121.3.236 · Cited by 41
Repeat-Associated Non-AUG Translation and Its Impact in Neurodegenerative Disease
Kearse, M. G., & Todd, P. K. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0292-z · Cited by 43
The effects of aging on the BTBR mouse model of autism spectrum disorder
Jasien, J., Daimon, C. M., Wang, R., Shapiro, B. K., Martin, B., & Maudsley, S. R. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00225 · Cited by 42
Siaw, G. E.-L., Liu, I., Lin, P.-Y., Been, M. D., & Hsieh, T. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1605517113 · Cited by 41
Bhat, S. A., Henry, R. J., Blanchard, A. C., Stoica, B. A., Loane, D. J., & Faden, A. I. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14954 · Cited by 42
mGluR5 Negative Modulators for Fragile X: Treatment Resistance and Persistence
Stoppel, D. C., McCamphill, P. K., Senter, R. K., Heynen, A. J., & Bear, M. F. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.718953 · Cited by 42
Self-citationAutism as the Early Closure of a Neuroplastic Critical Period Normally Seen in Adolescence
Berger, J. M., Rohn, T. T., & Oxford, J. T. (2012) · Biological Systems Open Access · doi:10.4172/2329-6577.1000118 · Cited by 43
mGluR5 Ablation in Cortical Glutamatergic Neurons Increases Novelty-Induced Locomotion
Jew, C. P., Wu, C., Sun, H., Zhu, J., Huang, J.-Y., Yu, D., Justice, N. J., & Lu, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070415 · Cited by 42
Nanoscale synapse organization and dysfunction in neurodevelopmental disorders
Zieger, H. L., & Choquet, D. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105453 · Cited by 35
Scharkowski, F., Frotscher, M., Lutz, D., Körte, M., & Michaelsen‐Preusse, K. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw408 · Cited by 40
Arbab, T., Battaglia, F. P., Pennartz, C. M. A., & Bosman, C. A. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.02.011 · Cited by 40
Wallingford, J., Scott, A. L., Rodrigues, K., & Doering, L. C. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00268 · Cited by 38
Zhang, P., Abdelmohsen, K., Liu, Y., Tominaga, K., Yoon, J., Grammatikakis, I., Martindale, J. L., Zhang, Y., Becker, K. G., Yang, I. H., et al. (2015) · Nature Communications · doi:10.1038/ncomms9888 · Cited by 40
Genetic Animal Models for Autism Spectrum Disorder
Schroeder, J. C., Reim, D., Boeckers, T. M., & Schmeißer, M. J. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_407 · Cited by 40
Ceolin, L., Bouquier, N., Boubaker-Vitre, J., Rialle, S., Séverac, D., Valjent, E., Perroy, J., & Puighermanal, E. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00340 · Cited by 40
Montani, C., Gritti, L., Beretta, S., Verpelli, C., & Sala, C. (2018) · Developmental Neurobiology · doi:10.1002/dneu.22657 · Cited by 40
Santos, M. D., Salery, M., Forget, B., Perez, M. A. G., Bétuing, S., Boudier, T., Vanhoutte, P., Caboche, J., & Heck, N. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.03.014 · Cited by 46
Review of targeted treatments in fragile X syndrome
Ligsay, A., & Hagerman, R. J. (2016) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2016.01045 · Cited by 38
Geng, J., Khaket, T. P., Pan, J., Li, W., Zhang, Y., Ping, Y., Cobos, I., & Lu, B. (2023) · Developmental Cell · doi:10.1016/j.devcel.2023.03.002 · Cited by 37
Neurodevelopmental disorders and genetic testing: Current approaches and future advances
Sherr, E. H., Michelson, D. J., Shevell, M. I., Moeschler, J. B., Gropman, A. L., & Ashwal, S. (2013) · Annals of Neurology · doi:10.1002/ana.23950 · Cited by 36
Koon, A. C., & Chan, H. Y. E. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00070 · Cited by 36
Presynaptic protein synthesis and brain plasticity: From physiology to neuropathology
Perrone‐Capano, C., Volpicelli, F., Penna, E., Chun, J. T., & Crispino, M. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.102051 · Cited by 37
Autism and Epilepsy: Exploring the Relationship Using Experimental Models
Stafstrom, C. E., & Benke, T. A. (2015) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7511-15.4.206 · Cited by 37
Gandhi, R. M., Kogan, C. S., & Messier, C. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00070 · Cited by 36
Fmr1 KO and Fenobam Treatment Differentially Impact Distinct Synapse Populations of Mouse Neocortex
Wang, G. X., Smith, S. J., & Mourrain, P. (2014) · Neuron · doi:10.1016/j.neuron.2014.11.016 · Cited by 36
Lithium: A Promising Treatment for Fragile X Syndrome
Liu, Z., & Smith, C. B. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500077p · Cited by 39
Molecular Biomarkers in Fragile X Syndrome
Zafarullah, M., & Tassone, F. (2019) · Brain Sciences · doi:10.3390/brainsci9050096 · Cited by 36
Telias, M., Mayshar, Y., Amit, A., & Ben‐Yosef, D. (2015) · Stem Cells and Development · doi:10.1089/scd.2015.0220 · Cited by 35
Sidorov, M. S., Kaplan, E. S., Osterweil, E. K., Lindemann, L., & Bear, M. F. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1512878112 · Cited by 35
Self-citationMatić, K., Eninger, T., Bardoni, B., Davidovic, L., & Maček, B. (2014) · Journal of Proteome Research · doi:10.1021/pr5006372 · Cited by 33
RNA-Binding Protein Misregulation in Microsatellite Expansion Disorders
Goodwin, M., & Swanson, M. S. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-1221-6_10 · Cited by 33
FMRP Regulates Neurogenesis In Vivo in Xenopus laevis Tadpoles
Faulkner, R. L., Wishard, T. J., Thompson, C. K., Liu, H.-H., & Cline, H. T. (2014) · eNeuro · doi:10.1523/eneuro.0055-14.2014 · Cited by 33
Brandalise, F., Kalmbach, B. E., Mehta, P., Thornton, O., Johnston, D., Zemelman, B. V., & Brager, D. H. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1670-19.2020 · Cited by 32
Auditory hypersensitivity and processing deficits in a rat model of fragile X syndrome
Auerbach, B. D., Manohar, S., Radziwon, K. E., & Salvi, R. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105541 · Cited by 34
Mercaldo, V., Vidimova, B., Gastaldo, D., Fernández, E., Lo, A. C., Cencelli, G., Pedini, G., Rubeis, S. D., Longo, F., Klann, E., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.03.008 · Cited by 32
Pathogenesis of Börjeson-Forssman-Lehmann syndrome: Insights from PHF6 function
Jahani‐Asl, A., Cheng, C., Zhang, C., & Bonni, A. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.09.011 · Cited by 37
Ji, B., Higa, K. K., Kim, M., Zhou, L., Young, J. W., Geyer, M. A., & Zhou, X. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu285 · Cited by 32
Zapata‐Muñoz, J., Villarejo‐Zori, B., Largo‐Barrientos, P., & Boya, P. (2021) · Cell Stress · doi:10.15698/cst2021.07.253 · Cited by 33
A decade of the anaphase-promoting complex in the nervous systemPreprint
Huang, J., & Bonni, A. (2016) · Genes & Development · doi:10.1101/gad.274324.115 · Cited by 31
Inhibition of Spontaneous Recovery of Fear by mGluR5 after Prolonged Extinction Training
Mao, S.-C., Chang, C., Wu, C.-C., Orejarena, M. J., Manzoni, O. J., & Gean, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059580 · Cited by 30
RetractedExcessive proteostasis contributes to pathology in fragile X syndrome
Louros, S. R., Seo, S. S., Maio, B., Martinez‐Gonzalez, C., Gonzalez‐Lozano, M. A., Muscas, M., Verity, N. C., Wills, J. C., Li, K. W., Nolan, M. F., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.11.012 · Cited by 32
Sleep and Synaptic Homeostasis
Vyazovskiy, V. V., & Faraguna, U. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_301 · Cited by 35
Wang, H., Morishita, Y., Miura, D., Naranjo, J. R., Kida, S., & Zhuo, M. (2012) · Molecular Brain · doi:10.1186/1756-6606-5-27 · Cited by 30
Zhang, K., Li, Y., Guo, Y., Zheng, K.-Y., Yang, Q., Yang, L., Wang, X., Song, Q., Chen, T., Zhuo, M., et al. (2017) · Brain · doi:10.1093/brain/awx265 · Cited by 30
Golden, C. E. M., Breen, M. S., Koro, L., Sonar, S., Niblo, K., Browne, A., Burlant, N., Di Marino, D., De Rubeis, S., Baxter, M. G., et al. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz029 · Cited by 29
Seizing an Opportunity for the Endocannabinoid System
Alger, B. E. (2014) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7597-14.5.272 · Cited by 28
Wang, T., de Kok, L. G. C., Willemsen, R., Elgersma, Y., & Borst, J. G. G. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00234 · Cited by 31
Astrocytes and developmental plasticity in fragile X.
Cheng, C., Sourial, M., & Doering, L. C. (2012) · Neural Plasticity · doi:10.1155/2012/197491 · Cited by 28
Prilutsky, D., Kho, A. T., Palmer, N., Bhakar, A. L., Smedemark-Margulies, N., Kong, S. W., Margulies, D. M., Bear, M. F., & Kohane, I. S. (2015) · Molecular Autism · doi:10.1186/s13229-015-0061-9 · Cited by 27
Self-citationSeese, R. R., Le, A. A., Wang, K., Cox, C. D., LYNCH, G. S., & Gall, C. M. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104604 · Cited by 29
Rizk, M., Saker, Z., Harati, H., Fares, Y., Bahmad, H. F., & Nabha, S. M. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06237-9 · Cited by 27
Synaptic Plasticity in Mouse Models of Autism Spectrum Disorders
Chung, L., Bey, A. L., & Jiang, Y. (2012) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2012.16.6.369 · Cited by 27
Metadata
- Authors
- Bhakar, A. L., Dölen, G., & Bear, M. F.
- Affiliations
- Howard Hughes Medical Institute (US)
- Stanford Medicine (US)
- Venue
- Annual Review of Neuroscience
- Publisher
- Annual Reviews
- Published
- 2012-07-21
- Volume
- 35
- Issue
- 1
- Pages
- 417-443
- ISSN
- 0147-006X (ISSN-L)
- 1545-4126
- PMC
- PMC4327822
- OpenAlex
- W2146760872
- Cited by
- 370
- References
- 207
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 13 · 2023: 17 · 2022: 14 · 2021: 24 · 2020: 16 · 2019: 21 · 2018: 31 · 2017: 29 · 2016: 37 · 2015: 43 · 2014: 49 · 2013: 42 · 2012: 17
- FWCI
- 5.90
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annual Review of Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- PMC
- Funders
- Howard Hughes Medical Institute
- National Institute of Mental Health (F30MH067431)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Keywords
- fragile X syndrome, FMRP, intellectual disability, autism spectrum disorder, metabotropic glutamate receptors, local protein synthesis, synaptic plasticity, mRNA-binding proteins
- MeSH terms
- Animals, Brain, Disease Models, Animal, Fragile X Syndrome, Gene Expression Regulation, Humans, Models, Biological, Nerve Tissue Proteins, Neuronal Plasticity, RNA, Synapses, Protein Biosynthesis, Signal Transduction, Receptors, Metabotropic Glutamate, Fragile X Mental Retardation Protein, Fragile X Messenger Ribonucleoprotein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
